Bleakley Financial Group’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.54M Buy
29,622
+1,434
+5% +$397K 0.08% 194
2026
Q1
$8.33M Buy
28,188
+1,192
+4% +$354K 0.13% 132
2025
Q4
$7.37M Buy
26,996
+6,671
+33% +$1.81M 0.13% 136
2025
Q3
$5.49M Sell
20,325
-3,973
-16% -$1.08M 0.13% 143
2025
Q2
$6.7M Buy
24,298
+2,147
+10% +$584K 0.17% 117
2025
Q1
$5.88M Buy
22,151
+9,593
+76% +$2.37M 0.19% 109
2024
Q4
$2.92M Sell
12,558
-882
-7% -$203K 0.09% 191
2024
Q3
$2.97M Sell
13,440
-641
-5% -$133K 0.09% 187
2024
Q2
$2.77M Buy
14,081
+2,504
+22% +$517K 0.08% 231
2024
Q1
$2.49M Sell
11,577
-92
-0.8% -$19.3K 0.07% 253
2023
Q4
$2.46M Buy
11,669
+719
+7% +$153K 0.08% 242
2023
Q3
$2.19M Sell
10,950
-192
-2% -$38.2K 0.08% 233
2023
Q2
$2.06M Buy
11,142
+784
+8% +$145K 0.06% 264
2023
Q1
$1.98M Buy
10,358
+2,243
+28% +$406K 0.07% 255
2022
Q4
$1.36M Buy
+8,115
New +$1.41M 0.05% 326

Other funds holding CME

Bleakley Financial Group's CME Position: Q2 2026 in Review

Bleakley Financial Group increased its CME Group (CME) stake by 5.1% in Q2 2026, buying an estimated $397K and bringing the position to 29,622 shares worth $6.54M. The position accounts for 0.08% of the portfolio, ranked #194.

Bleakley Financial Group first reported a position in CME in Q4 2022 and has held it in 15 quarters since. The position peaked at $8.33M in Q1 2026. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Bleakley Financial Group held 29,622 shares of CME Group worth $6.54M as of Q2 2026.
  • Bleakley Financial Group bought 1,434 CME Group shares in Q2 2026, an estimated $397K.
  • CME Group made up 0.08% of Bleakley Financial Group's portfolio in Q2 2026, its #194 holding.
  • Bleakley Financial Group first reported a position in CME Group in Q4 2022 and has held it in 15 quarters since.
  • Bleakley Financial Group's CME Group position peaked at $8.33M in Q1 2026.
  • 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Bleakley Financial Group's 13F filing for Q2 2026, filed 5 Aug 2026.